IVIg vs placebo or no treatment
Event‐free survival (no death, transplant, or left ventricular assist device) ‐ adults with myocarditis · adults with acute myocarditis
It is very uncertain whether intravenous immunoglobulin changes event‐free survival (risk of death, cardiac transplant, or left… compared with placebo or no treatment (very low certainty).
1 finding from 1 review
- Intravenous immunoglobulin for presumed viral myocarditis in children and adults 2020 · Cochrane Headline outcomes onlyRR 1.76 [0.48, 6.4]1 study · 62 participantsVery low